App for Adverse Events to Oral Chemotherapy - Pilot Study
Not Applicable
Active, not recruiting
- Conditions
- Breast NeoplasmsChemotherapeutic Toxicity
- Registration Number
- NCT05743686
- Lead Sponsor
- Julie Lemieux
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria:<br><br> - >=18 years of age<br><br> - metastatic breast cancer<br><br> - receiving oral chemotherapy (palbociclib, everolimus, or capecitabine)<br><br> - possess an smartphone, a tablet, or a personal compiter<br><br>Exclusion Criteria:<br><br> - cognitive impairments
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of calls
- Secondary Outcome Measures
Name Time Method